Advances in Drug development & Approvals Landscape, and Industry Partnerships.
- Published in:
- 2014
- By:
- Publication type:
- Proceeding
Works matching DE "BIOTECHNOLOGY Industry Organization"
Results: 38
1
2
FDA at BIO 2011 - Weighing a hefty mission: Where is the balance?
- Published in:
- Journal of Commercial Biotechnology, 2011, v. 17, n. 4, p. 365, doi. 10.1057/jcb.2011.24
- By:
- Publication type:
- Article
3
Evergreening biologics.
- Published in:
- Journal of Generic Medicines, 2011, v. 8, n. 3, p. 132, doi. 10.1177/1741134311420207
- By:
- Publication type:
- Article
4
20 Jahre BIO Deutschland e. V.
- Published in:
- Trillium-Diagnostik, 2024, v. 22, n. 4, p. 307
- By:
- Publication type:
- Article
5
Innovation pays.
- Published in:
- 2012
- By:
- Publication type:
- Opinion
6
KALENDARZ IMPREZ.
- Published in:
- Polimery, 2014, v. 59, n. 3, p. 274
- Publication type:
- Article
7
Decisions in First-in-Human Trials.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
8
BIO Breeds Hope.
- Published in:
- 2009
- By:
- Publication type:
- Proceeding
9
US biotechnology groups merge.
- Published in:
- Nature, 1993, v. 361, n. 6408, p. 106, doi. 10.1038/361106b0
- By:
- Publication type:
- Article
10
Large drugs outdo small.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 4, p. 296, doi. 10.1038/nbt0411-296a
- By:
- Publication type:
- Article
11
BIO's track record on emerging companies.
- Published in:
- 2010
- By:
- Publication type:
- Letter
12
One year in—Obama's biotech scorecard.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 3, p. 193, doi. 10.1038/nbt0310-193
- By:
- Publication type:
- Article
13
PhRMA wants you!
- Published in:
- 2010
- Publication type:
- Editorial
14
Biotechs get $1 billion windfall in R&D tax credits.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 12, p. 1066, doi. 10.1038/nbt1209-1066c
- By:
- Publication type:
- Article
15
Land use stirs biofuels ruckus.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 2, p. 109, doi. 10.1038/nbt0209-109b
- By:
- Publication type:
- Article
16
Join the dots.
- Published in:
- 2008
- Publication type:
- Editorial
17
UK strong arms industry over drug pricing.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 8, p. 846, doi. 10.1038/nbt0808-846c
- By:
- Publication type:
- Article
18
Who speaks for small biotech?
- Published in:
- Nature Biotechnology, 2007, v. 25, n. 7, p. 693, doi. 10.1038/nbt0707-693
- Publication type:
- Article
19
Democrats prioritize pricing, generics and drug safety.
- Published in:
- Nature Biotechnology, 2007, v. 25, n. 2, p. 150, doi. 10.1038/nbt0207-150
- By:
- Publication type:
- Article
20
Response to The fit between organic and pharma crops in North Carolina.
- Published in:
- Nature Biotechnology, 2007, v. 25, n. 2, p. 167, doi. 10.1038/nbt0207-167
- Publication type:
- Article
21
BIO reaches adolescence.
- Published in:
- Nature Biotechnology, 2006, v. 24, n. 4, p. 381, doi. 10.1038/nbt0406-381
- By:
- Publication type:
- Article
22
Boldness, but with realism.
- Published in:
- 2004
- Publication type:
- Editorial
23
Drugs in crops-the unpalatable truth.
- Published in:
- 2004
- Publication type:
- Editorial
24
Bid to limit prices on drugs using `public' discoveries.
- Published in:
- Nature, 1998, v. 393, n. 6683, p. 297, doi. 10.1038/30570
- By:
- Publication type:
- Article
25
Innovative Approaches in Drug Development.
- Published in:
- Journal of Biopharmaceutical Statistics, 2007, v. 17, n. 5, p. 775, doi. 10.1080/10543400701513926
- By:
- Publication type:
- Article
26
US acts to lengthen term of patents to help biotechnology.
- Published in:
- Nature, 1999, v. 400, n. 6745, p. 604, doi. 10.1038/23099
- By:
- Publication type:
- Article
27
US bioindustry calls for government bailout.
- Published in:
- Nature, 2008, v. 456, n. 7224, p. 852, doi. 10.1038/456852a
- Publication type:
- Article
28
Making it in the biotech business.
- Published in:
- Nature, 2005, v. 435, n. 7038, p. 124, doi. 10.1038/nj7038-124a
- By:
- Publication type:
- Article
29
Biotech industry calls for more protection of patient information.
- Published in:
- BioScience, 1997, v. 47, n. 1, p. 64
- Publication type:
- Article
30
Synthetic biology: Cultural divide.
- Published in:
- Nature, 2014, v. 509, n. 7499, p. 152, doi. 10.1038/509152a
- By:
- Publication type:
- Article
31
Life sciences workforce trends evolve with the industry.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 1, p. 107, doi. 10.1038/nbt.3116
- By:
- Publication type:
- Article
32
How big is the bioeconomy?
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 7, p. 598, doi. 10.1038/nbt.2966
- Publication type:
- Article
33
The service-based bioeconomy.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 7, p. 597, doi. 10.1038/nbt.2961
- Publication type:
- Article
34
BIO response to December editorial.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 2, p. 131, doi. 10.1038/nbt.2818
- By:
- Publication type:
- Article
35
Recent patent applications in computational biotechnologies.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 1, p. 30, doi. 10.1038/nbt.2483
- By:
- Publication type:
- Article
36
Threat to global GM soybean access as patent nears expiry.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 1, p. 10, doi. 10.1038/nbt0113-10c
- By:
- Publication type:
- Article
37
BIO marches to Congress with growth package in hand.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 9, p. 776, doi. 10.1038/nbt0911-776
- By:
- Publication type:
- Article
38
Industry access to the literature.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 7, p. 571, doi. 10.1038/nbt.1909
- By:
- Publication type:
- Article